Objective: To establish a suitable experimental model of bone and live
r micrometastases from human prostate cancer for evaluating antitumor
agents. Methods: PC-3 cells, an androgen-independent prostate cancer c
ell line, were inoculated into the chorioallantoic membrane vein of 10
-day-old chick embryos (10(6) cells/egg), The polymerase chain reactio
n product fur the human beta-globin gene in chick embryo femur and liv
er was quantified at various time points after inoculation, when immun
ohistochemical staining was done for Ki-67 antigen and cytokeratin. Th
e antitumor effect of suramin was evaluated using the model, as was re
gional blood flow after thallium injection. Results: Micrometastases w
ere identified in bone and liver 1 day after inoculation and grew to f
orm established metastatic foci in all embryos. Suramin showed signifi
cant antitumor effect for liver metastases, but not for those in bone
where blood flow was relatively low. Conclusion: The chick embryo syst
em provides a highly reproducible model for bone and liver micrometast
ases from human prostate cancer: suitable for evaluating antineoplasti
c agents at an early stage of the metastatic process.